Tci Wealth Advisors, Inc. Fulgent Genetics, Inc. Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$29.23 - $40.28 $3,653 - $5,035	-125 Reduced 83.89%	24 $0
Q1 2022 Apr 29, 2022	BUY	$49.85 - $96.11 $2,542 - $4,901	51 Added 52.04%	149 $9,000
Q4 2021 Jan 24, 2022	BUY	$77.3 - $105.0 $463 - $630	6 Added 6.52%	98 $10,000
Q3 2021 Oct 29, 2021	BUY	$74.87 - $110.87 $4,567 - $6,763	61 Added 196.77%	92 $8,000
Q2 2021 Aug 02, 2021	BUY	$66.8 - $100.45 $801 - $1,205	12 Added 63.16%	31 $3,000
Q1 2021 Apr 29, 2021	BUY	$59.3 - $183.85 $1,126 - $3,493	19 New	19 $2,000

208

17.1M

2.36M

47.9K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $511M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.